Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to approval will be clear as soon as the vaccine maker and the regulator agree on the ...

(Reuters) -Drugmaker Viatris beat Wall Street estimates for first-quarter profit and revenue on Thursday, helped by sales of its branded drugs in China. The company's shares, which rose over 4% in ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

Novavax on Thursday swung to a first-quarter profit from a year-ago loss, helped by reduced costs related to the development and sale of its COVID-19 vaccines, its only product on the market.

The Court of Appeal has upheld a British watchdog's 99 million pound ($131.94 million) fine against owners of Advanz Pharma ...

Viatris said on Thursday that its fast-acting form of generic pain drug meloxicam met the main goals of two late-stage studies.

Italian drug maker Recordati posted an 11.9% increase in its first-quarter net revenue on Thursday to 680.0 million euros ($767.52 million) and confirmed its guidance for 2025.

It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...

U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...

OpenAI and the U.S. Food and Drug Administration have been meeting to discuss the health regulator's use of AI, technology ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...